Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry|October 30, 2007
Novel imidazo[1,2-a]pyrazine derivatives as potent reversible inhibitors of the gastric H+/K+-ATPasePeter Jan Zimmermann, Christof Brehm, Wilm Buhr, et al.Bioorganic & Medicinal Chemistry|October 27, 2007
5-Substituted 1H-pyrrolo[3,2-b]pyridines as inhibitors of gastric acid secretionAndreas Marc Palmer, Gabriela Münch, Christof Brehm, et al.Bioorganic & Medicinal Chemistry Letters|August 29, 2007
Novel indanyl-substituted imidazo[1,2-a]pyridines as potent reversible inhibitors of the gastric H+/K+-ATPasePeter Jan Zimmermann, Wilm Buhr, Christof Brehm, et al.Bioorganic & Medicinal Chemistry|September 21, 2007
Preparation of tetrahydroimidazo[2,1-a]isoquinolines and their use as inhibitors of gastric acid secretionAndreas Marc Palmer, Burkhard Grobbel, Christof Brehm, et al.Journal of Medicinal Chemistry|November 3, 2007
Synthesis and evaluation of 7H-8,9-dihydropyrano[2,3-c]imidazo[1,2-a]pyridines as potassium-competitive acid blockersAndreas M Palmer, Burkhard Grobbel, Cornelia Jecke, et al.Bioorganic & Medicinal Chemistry|November 26, 2008
Spiro(imidazo[1,2-a]pyrano[2,3-c]pyridine-9-indenes) as inhibitors of gastric acid secretionAndreas Marc Palmer, Sandra Chrismann, Gabriela Münch, et al.Journal of the American Chemical Society|February 20, 2004
A concise synthesis of the octalactinsPaul T O'Sullivan, Wilm Buhr, Mary Ann M Fuhry, et al.Journal of Medicinal Chemistry|April 13, 2010
Tetrahydrochromenoimidazoles as potassium-competitive acid blockers (P-CABs): structure-activity relationship of their antisecretory properties and their affinity toward the hERG channelAndreas M Palmer, Vittoria Chiesa, Anja Schmid, et al.Pageof 1